Skip to content

Clinical Study on the Treatment of Residual Dizziness after Positional Vertigo Reduction by Acupuncture Therapy for Benign Positional Vertigo

Clinical Study on the Treatment of Residual Dizziness after Positional Vertigo Reduction by Acupuncture Therapy for Benign Positional Vertigo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129448
Enrollment
Unknown
Registered
2026-08-05
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign paroxysmal positional vertigo

Interventions

Experimental group:Acupuncture (GV20, SI19, bilateral GB20, bilateral TE3, bilateral Yun-ting area, Xinwu alternated
syndrome-based supplementary points) plus Brandt-Daroff exercises
every other day, 2–3 times/week, for 2 weeks or until complete resolution. Sample size 62.
Control group:Brandt-Daroff vestibular rehabilitation alone, with clinician contact time matched to the intervention arm. Sample size 62

Sponsors

Shuguang Hospital (Anhui) Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. BPPV was successfully restored by manual manipulation and residual dizziness was confirmed; 2. Idiopathic, first-episode BPPV; 3. Able to read and write the patient self-assessment scale, willing and able to follow the treatment and follow-up arrangements.

Exclusion criteria

Exclusion criteria: 1. Head trauma, prolonged postoperative bed rest, exposure to ototoxic drugs or history of sudden deafness; 2. Other peripheral vestibular disorders, secondary BPPV caused by petaloid stones or multiple canal involvement; 3. Central positional vertigo (such as vestibular migraine, cerebellar disease); 4. Pregnancy, or refusal to undergo repositioning/needle therapy after full explanation; 5. Recent use of vestibular suppressants that may mask nystagmus.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) scores of dizziness after 2 weeks of treatment;

Secondary

MeasureTime frame
DHI total score at 2 weeks;Time to complete resolution of residual dizziness (days);;Post-treatment high-stimulation-rate ABR abnormality rate;

Countries

China

Contacts

Public ContactWang Zhibin

Shuguang Hospital (Anhui) Affiliated to Shanghai University of Traditional Chinese Medicine

565331227@qq.com+86 551 6273 6750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026